C1q tumour necrosis factor related protein 1Alternative Names: C1q TNF Related Protein 1; C1QTNF1; CTRP 1; zsig37
Latest Information Update: 14 Sep 2010
At a glance
- Originator ZymoGenetics
- Developer Seattle Life Sciences
- Class Antithrombotics; Proteins
- Mechanism of Action Platelet activating factor inhibitors; Platelet aggregation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Thrombosis